FDA Inspection 962120 — Lupin Limited

Lupin Limited — FEI 3002807511

The FDA completed an inspection of Lupin Limited on February 19, 2016 in Mandideep. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 19, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mandideep (India)